SCHEMBL2444564

SCHEMBL2444564

CCOc1c(F)cc(/C=N\O)cc1Cl

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.71
PKM P14618 2/20 0.63
CYP1A2 P05177 1/20 0.63
CYP3A4 P08684 1/20 0.63
CYP2C19 P33261 1/20 0.63
HTT P42858 5/20 0.60
MEN1 O00255 4/20 0.60
KMT2A Q03164 4/20 0.60
MAPT P10636 3/20 0.60
HPGD P15428 3/20 0.60
SMN1; SMN2 Q16637 7/20 0.51
HSD17B10 Q99714 2/20 0.49
MAPK1 P28482 1/20 0.46
POLB P06746 2/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
LMNA P02545 4/20 0.43
NPSR1 Q6W5P4 1/20 0.43
TSHR P16473 1/20 0.42
NFKB1 P19838 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2444566 1.00 ALDH1A1 (0.71) ALDH1A1PKMCYP1A2CYP3A4CYP2C19
SCHEMBL2010577 0.80 ALDH1A1 (0.52) ALDH1A1PKMCYP1A2CYP3A4CYP2C19
SCHEMBL2449843 0.74 ALDH1A1 (0.59) ALDH1A1PKMCYP1A2CYP3A4CYP2C19
SCHEMBL2449841 0.74 ALDH1A1 (0.59) ALDH1A1PKMCYP1A2CYP3A4CYP2C19
SCHEMBL3841470 0.73 LMNA (0.40) ALDH1A1PKMCYP1A2CYP3A4CYP2C19
SCHEMBL2445183 0.72 LMNA (0.67) ALDH1A1PKMCYP1A2CYP3A4CYP2C19
SCHEMBL2445186 0.72 LMNA (0.67) ALDH1A1PKMCYP1A2CYP3A4CYP2C19
SCHEMBL12504658 0.72 LMNA (0.39) ALDH1A1PKMCYP1A2CYP3A4CYP2C19
SCHEMBL12468232 0.70 HTR2A (0.39) ALDH1A1PKMHTTMEN1KMT2A
SCHEMBL18502973 0.70 HPGD (0.49) ALDH1A1PKMCYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2366704-B1 Inhibitors of serine proteases VERTEX PHARMA (US) 2013-10-23 EP disclosed
EP-2631238-A1 Spirocyclic inhibitors of serine proteases for the treatment of hcv infections VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-08-28 EP disclosed
EP-1917269-B1 INHIBITORS OF SERINE PROTEASES VERTEX PHARMA (US) 2011-10-26 EP disclosed
EP-2366704-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-21 EP disclosed
EP-2364984-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-14 EP disclosed